Curis (NasdaqCM:CRIS) Q3 2026 Earnings call November 12, 2026 04:30 PM ET Company ParticipantsDiantha Duvall - CFOJim Dentzer - President and CEOConference Call ParticipantsYale Jen - AnalystDanya Ben-Hail - AnalystSara Nik - AnalystOperatorCall is being recorded on Thursday, November 12, 2026. I would now like to turn the conference over to your host, Diantha Duvall.Diantha DuvallThank you, and welcome to Curis' third quarter 2026 business update call. Before we begin, I would like to encourage everyone to ...

Curis (NasdaqCM:CRIS) Q3 2026 Earnings call November 12, 2026 04:30 PM ET Speaker0Call is being recorded on Thursday, November 12, 2026. I would now like to turn the conference over to your host, Diantha Duvall.Speaker1Thank you, and welcome to Curis' third quarter 2026 business update call. Before we begin, I would like to encourage everyone to go to the investor section of our website at www.curis.com to find our third quarter 2026 business update press release and related financial tables. I would also l ...

Curis Provides Third Quarter 2026 Business Update Curis Provides Third Quarter 2026 Business Update Curis, Inc. Nov 12, 2026, 16:01 ET Management to host conference call and webcast today at 4:30 p.m. ET LEXINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its financial and operating results for the third quarter ended September 30, ...